[HLFG] QoQ Cumulative Quarter Result on 31-Mar-2020 [#3]

Announcement Date
29-May-2020
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2020
Quarter
31-Mar-2020 [#3]
Profit Trend
QoQ- 34.15%
YoY- -8.15%
View:
Show?
Cumulative Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 3,118,177 1,498,803 5,257,825 3,828,666 2,686,167 1,326,166 5,278,010 -29.47%
PBT 1,954,980 987,761 3,299,521 2,441,237 1,837,881 913,649 3,505,640 -32.12%
Tax -304,969 -132,930 -520,566 -427,767 -337,218 -170,175 -591,379 -35.56%
NP 1,650,011 854,831 2,778,955 2,013,470 1,500,663 743,474 2,914,261 -31.44%
-
NP to SH 1,114,615 587,033 1,857,502 1,332,361 993,161 490,201 1,919,359 -30.27%
-
Tax Rate 15.60% 13.46% 15.78% 17.52% 18.35% 18.63% 16.87% -
Total Cost 1,468,166 643,972 2,478,870 1,815,196 1,185,504 582,692 2,363,749 -27.09%
-
Net Worth 21,780,085 21,553,481 20,895,915 20,195,879 19,799,451 19,498,958 19,195,767 8.74%
Dividend
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Div 122,449 - 430,843 147,498 147,672 147,978 480,466 -59.63%
Div Payout % 10.99% - 23.19% 11.07% 14.87% 30.19% 25.03% -
Equity
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Net Worth 21,780,085 21,553,481 20,895,915 20,195,879 19,799,451 19,498,958 19,195,767 8.74%
NOSH 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 1,147,516 0.00%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 52.92% 57.03% 52.85% 52.59% 55.87% 56.06% 55.22% -
ROE 5.12% 2.72% 8.89% 6.60% 5.02% 2.51% 10.00% -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 275.02 132.19 463.74 337.45 236.47 116.50 461.38 -29.06%
EPS 98.30 51.80 163.60 117.30 87.40 43.10 167.80 -29.87%
DPS 10.80 0.00 38.00 13.00 13.00 13.00 42.00 -59.39%
NAPS 19.21 19.01 18.43 17.80 17.43 17.13 16.78 9.39%
Adjusted Per Share Value based on latest NOSH - 1,147,516
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 271.73 130.61 458.19 333.65 234.09 115.57 459.95 -29.48%
EPS 97.13 51.16 161.87 116.11 86.55 42.72 167.26 -30.28%
DPS 10.67 0.00 37.55 12.85 12.87 12.90 41.87 -59.63%
NAPS 18.9802 18.7827 18.2097 17.5996 17.2542 16.9923 16.7281 8.74%
Price Multiplier on Financial Quarter End Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 -
Price 18.06 14.28 13.10 13.68 16.90 16.26 18.54 -
P/RPS 6.57 10.80 2.82 4.05 7.15 13.96 4.02 38.54%
P/EPS 18.37 27.58 8.00 11.65 19.33 37.76 11.05 40.11%
EY 5.44 3.63 12.51 8.58 5.17 2.65 9.05 -28.66%
DY 0.60 0.00 2.90 0.95 0.77 0.80 2.27 -58.64%
P/NAPS 0.94 0.75 0.71 0.77 0.97 0.95 1.10 -9.90%
Price Multiplier on Announcement Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 26/02/21 27/11/20 28/08/20 29/05/20 26/02/20 27/11/19 28/08/19 -
Price 16.96 16.10 12.34 13.28 15.70 16.76 16.04 -
P/RPS 6.17 12.18 2.66 3.94 6.64 14.39 3.48 46.23%
P/EPS 17.25 31.10 7.53 11.31 17.96 38.92 9.56 47.94%
EY 5.80 3.22 13.28 8.84 5.57 2.57 10.46 -32.38%
DY 0.64 0.00 3.08 0.98 0.83 0.78 2.62 -60.75%
P/NAPS 0.88 0.85 0.67 0.75 0.90 0.98 0.96 -5.61%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment